Cyclic Carbonate Monomer Synthesis via CDI Cyclization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for synthesizing cyclic carbonate monomers, particularly those derived from bis-methoxy propionic acid, face challenges such as harsh alkylation conditions, incompatibility with base-sensitive substrates, and the use of toxic reagents like triphosgene or chloroformate, which require additional steps and lead to impurities causing slow oligomerization.
Innovation Solution
The synthesis of cyclic carbonate monomers is achieved through an alkylation-cyclization and/or cyclization-esterification process using N,N′-carbonyldiimidazole (CDI), which allows for the formation of cyclic carbonate monomers without hazardous reagents and under mild conditions, enabling the incorporation of various functional groups and reducing the need for chromatographic purification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional alkylation conditions are used to install functional groups and cyclize the diol, then the desired cyclic carbonate monomer is formed, but harsh conditions are required that are incompatible with base-sensitive substrates
Solution Approach 1:
The patent changes the chemical parameters of the cyclization reaction by using N,N'-carbonyldiimidazole (CDI) instead of conventional triphosgene or chloroformate reagents. This reagent substitution enables the cyclization to proceed under mild, neutral conditions that are compatible with base-sensitive substrates, while still achieving efficient cyclic carbonate formation. The CDI reagent system allows for functional group installation and cyclization without requiring harsh basic conditions.
2Reliability
If triphosgene or chloroformate reagents are used to achieve cyclization to the carbonate, then cyclization is achieved, but toxic reagents are used requiring additional safety measures and purification steps
Solution Approach 1:
The patent replaces toxic triphosgene and chloroformate reagents with N,N'-carbonyldiimidazole (CDI), which is significantly less toxic and easier to handle. The CDI reagent system converts the harmful aspect of conventional reagents into a beneficial alternative that maintains cyclization efficiency while eliminating the need for specialized safety measures and extensive purification procedures. The imidazole byproducts from CDI are non-toxic and can be removed by simple aqueous workup.
3Reliability
If conventional cyclization methods are used, then cyclic carbonate monomer is formed, but small impurities from the cyclization step trigger slow oligomerization of the carbonate monomer
Solution Approach 1:
The patent employs simple aqueous workup procedures to extract and remove imidazole byproducts and other small impurities from the reaction mixture after cyclization. This extraction step effectively separates the desired cyclic carbonate monomer from potential oligomerization-triggering impurities, thereby preventing slow oligomerization and maintaining monomer stability without requiring complex purification protocols.
4Manufacturing precision
If protection-deprotection schemes are used to enable selective transformations, then selective functional group installation is achieved, but additional steps are required increasing process complexity
Solution Approach 1:
The patent uses N,N'-carbonyldiimidazole (CDI) to pre-activate the carboxylic acid functional group before cyclization, creating a reactive mixed anhydride intermediate that selectively reacts with the diol hydroxyl groups. This preliminary activation step enables selective transformation without requiring protection-deprotection schemes, as the CDI reagent inherently directs the reaction to the desired products through its specific reactivity pattern, thereby reducing the total number of synthesis steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides improved yields and access to a broad range of functionalized cyclic carbonate monomers, facilitating their polymerization into polycarbonates with tailored properties without the use of toxic reagents or harsh conditions.
Implementation Method 1
cyclizing a functionalized diol monomer with N,N'-carbonyldiimidazole, wherein the cyclizing can produce a mixture of a cyclic carbonate monomer and an imidazole carbamate product
Implementation Method 2
activating the imidazole carbamate product with an acid, wherein the activating can promote cyclization of the imidazole carbamate product into the cyclic carbonate monomer
Data Source
AI summary
Techniques regarding the synthesis of cyclic carbonate monomers are provided. For example, one or more embodiments described herein can comprise a method, which can include cyclizing a functionalized diol monomer with N,N′-carbonyldiimidazole, wherein the cyclizing produces a cyclic carbonate monomer and an imidazole carbamate. The method can also include activating the imidazole carbamate with an acid, wherein the activating promotes cyclization of the imidazole carbamate into the cyclic carbonate monomer.